VTEU: Phase I Clinical Trial of a Chikungunya Vaccine

VTEU：基孔肯雅疫苗的 I 期临床试验

• 批准号: 9361362
• 负责人: PATRICIA WINAKUR
• 金额: $ 37.13万
• 依托单位: UNIVERSITY OF IOWA
• 依托单位国家: 美国
• 财政年份: 2015
• 资助国家: 美国
• 起止时间: 2015-11-02 至 2016-06-16
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9361362
• 关键词: Communicable Diseases; Conduct Clinical Trials; Contracts; Individual; Phase I Clinical Trials; Population; Resources; Vaccines; chikungunya; combat; design; named group; programs

This program is comprised of a consortium of individual contracts within academic centers and organizations that provide a ready resource for the design and conduct of clinical trials to evaluate promising products to combat infectious diseases. In general, products will be evaluated in normal healthy populations; however, access to special populations is also available.

该计划由学术中心和组织内的一个个人合同组成，这些联合为设计和行为提供了现成的资源，以评估有前途的产品来打击传染病。 通常，将在正常健康人群中评估产品；但是，也可以使用特殊人群。